1 citations
,
November 2008 in “Acta crystallographica”
Scientists successfully created and analyzed the structure of a part of the human androgenreceptor with specific modulators and a peptide to understand how it binds differently in various tissues.
Researchers developed reliable models to predict how well certain compounds bind to androgenreceptors, emphasizing the importance of atomic electronegativity.
The relative strength of Pyrilutamide compared to RU58841 in terms of androgenreceptorbinding affinity. It has been noted that Pyrilutamide is 4x stronger than RU58841, with a higher binding affinity than DHT itself.
RU and Pyri block androgenreceptors to prevent hair loss but may also hinder hair regrowth since they prevent testosterone, which can stimulate hair growth, from binding to these receptors. The user is questioning if this understanding is correct.
Pyrilutimide and CB-03-01, two treatments for hair loss, have similar clinical trial results despite different binding affinities to androgenreceptors. Factors other than binding affinity, like the time a drug stays bound to the receptor, may influence their effectiveness.
Bicalutamide blocks androgenreceptors, preventing testosterone and DHT from binding, which can help with hair loss but may cause feminization. It is not recommended for those who do not want feminization effects.